Sandia Labs manufactures its first devices capable of supporting 200 trapped ion qubits.
Sandia National Laboratories has produced its first lot of a new world-class ion trap, a central component for certain quantum computers. This innovative device, termed the Enchilada Trap, enables researchers to construct more powerful machines, propelling the experimental yet groundbreaking realm of quantum computing forward.
In addition to traps operated at Sandia, several traps will be used at Duke University for performing quantum algorithms. Duke and Sandia are research partners through the Quantum Systems Accelerator, one of five U.S. National Quantum Information Science Research Centers funded by the Department of Energy's Office of Science.
An ion trap is a type of microchip that holds electrically charged atoms, or ions. With more trapped ions, or qubits, a quantum computer can run more complex algorithms.
Jonathan Sterk points to the section of an ion trap trapped ion qubits travel in a close-up view of the trap inside a vacuum chamber at Sandia National Laboratories. Credit: Craig Fritz, Sandia National Laboratories
With sufficient control hardware, the Enchilada Trap could store and transport up to 200 qubits using a network of five trapping zones inspired by its predecessor, the Roadrunner Trap. Both versions are produced at Sandia's Microsystems Engineering, Science, and Applications fabrication facility.
According to Daniel Stick, a Sandia scientist and leading researcher with the Quantum Systems Accelerator, a quantum computer with up to 200 qubits and current error rates will not outperform a conventional computer for solving useful problems. However, it will enable researchers to test an architecture with many qubits that in the future will support more sophisticated quantum algorithms for physics, chemistry, data science, materials science, and other areas.
"We are providing the field of quantum computing room to grow and explore larger machines and more complicated programming," Stick said.
Sandia National Laboratories electrical engineer Ray Haltli optimizes parameters before placing gold wire bonds on an ion trap. When ready, the machine runs automatically, placing up to seven wires per second. Credit: Craig Fritz, Sandia National Laboratories
A forward-looking design
Sandia has researched, built, and tested ion traps for 20 years. To overcome a series of design challenges, the team combined institutional knowledge with new innovations.
For one, they needed space to hold more ions and a way to rearrange them for complex calculations. The solution was a network of electrodes that branches out similar to a family tree or tournament bracket. Each narrow branch serves as a place to store and shuttle ions.
Sandia had experimented with similar junctions in previous traps. The Enchilada Trap uses the same design in a tiled way so it can explore scaling properties of a smaller trap. Stick believes the branching architecture is currently the best solution for rearranging trapped ion qubits and anticipates that future, even larger versions of the trap will feature a similar design.
Another concern was the dissipation of electrical power on the Enchilada Trap, which could generate significant heat, leading to increased outgassing from surfaces, a higher risk of electrical breakdown, and elevated levels of electrical field noise. To address this issue, production specialists designed new microscopic features to reduce the capacitance of certain electrodes.
"Our team is always looking ahead," said Sandia's Zach Meinelt, the lead integrator on the project. "We collaborate with scientists and engineers to learn about the kind of technology, features, and performance improvements they will need in the coming years. We then design and fabricate traps to meet those requirements and constantly seek ways to further improve."
The research was funded by the US Department of Energy.
News
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
